Inventive Impex Private Limited
About Inventive Impex Private Limited
Data last updated:
Inventive Impex Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 September 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2009PTC193882. Its GSTIN is 07AACCI3028F2ZX (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Shubham Bansal and Anju Aggarwal.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at I – 4/130 Ground Floor Sector – 16 Rohini, New Delhi, Delhi, India – 110089.
As per the financials filed for FY 2025, the company reported a revenue of ₹48.8 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹17.11 Lakh (net margin 35.1%) and EBITDA of ₹27.46 Lakh (EBITDA margin 56.3%). Revenue has grown at a compounded annual rate (CAGR) of 205% over five years.
As per MCA filings, the company has open charges of ₹11.2 Cr and satisfied charges of ₹4.8 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Inventive Impex Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressI – 4/130 Ground Floor Sector – 16 Rohini, New Delhi, Delhi, India – 110089
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Inventive Impex Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Inventive Impex Private Limited
FY 2025 filings availableInventive Impex Private Limited reported revenue of ₹48.8 Lakh (up 307% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 205% over five years, including 307% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹27.46 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.11 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 56.3% | ||||
| Net Profit Margin | 35.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Inventive Impex Private Limited, buy the company report.
Board of directors of Inventive Impex Private Limited
Inventive Impex has 3 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shubham Bansal Also directs: Inventive Medicare (India) LLP, Fibrient Healthcare LLP, Ethico Pharma Private Limited and 2 more | Director | 26 Oct 2020 | 5 Years 11 Months | Current |
| Anju Aggarwal Also directs: RJ Global Ventures LLP, Adorellecare Private Limited, Promenade Lifecare Private Limited and 1 more | Director | 26 Oct 2020 | 5 Years 11 Months | Current |
| Dhruv Aggarwal Also directs: Promenade Lifecare Private Limited | Director | 10 Jun 2024 | 2 Years 4 Months | Current |
Peer comparison
Inventive Impex Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dolamind Pharmaceutical Private Limited | ₹48.9 Lakh (FY 2025) | 69.0% | Mumbai, Maharashtra, India | |||
| Amitav Health Care Centre Private Limited | ₹48.9 Lakh (FY 2024) | 64.0% | Tal Jath, Dist Sangli, Maharashtra, India | |||
| Meddroid Pharmaceutical Private Limited | ₹48.84 Lakh (FY 2025) | 76.0% | New Delhi, Delhi, India | |||
| Styrax Healthcare Private Limited | ₹48.84 Lakh (FY 2024) | -21.0% | Amritsar, Punjab, India | |||
| Coxswain Bio Remedies Private Limited | ₹48.81 Lakh (FY 2024) | -21.0% | Hisar, Haryana, India | |||
| Inventive Impex Private Limitedthis company | ₹48.8 Lakh (FY 2025) | ₹17.11 Lakh | 35.1% | 307.0% | New Delhi, Delhi, India | |
| Pragyaa Pharmacy Private Limited | ₹48.79 Lakh (FY 2023) | 474.0% | Jaipur, Rajasthan, India | |||
| Stargenics India Private Limited | ₹48.77 Lakh (FY 2024) | 21.0% | Thane, Maharashtra, India | |||
| Manomay Life Care Private Limited | ₹48.74 Lakh (FY 2025) | 36.0% | Ranchi, Jharkhand, India | |||
| Clouds M Pharmaz Private Limited | ₹48.73 Lakh (FY 2025) | -28.0% | Patna, Bihar, India | |||
| Mgees Holitel Hotels Private Limited | ₹48.72 Lakh (FY 2025) | -31.0% | New Delhi, Delhi, India |
To see the full peer comparison of Inventive Impex Private Limited, buy the company report.
Auditor
Inventive Impex Private Limited is audited by DHIRAJ AGGARWAL & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DHIRAJ AGGARWAL & ASSOCIATES | FY 2023 | 036914N |
Shareholding
The shareholding of Inventive Impex Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Inventive Impex Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Mar 2023 | 100695599 | Others | ₹9.15 Cr | Open | |
| 25 Mar 2014 | 10502242 | Capital First Limited | ₹2.05 Cr | Open | |
| 29 Nov 2022 | 100702716 | Hdfc Bank Limited | ₹2 Cr | Satisfied | |
| 28 Dec 2018 | 100247111 | Hdfc Bank Limited | ₹2.8 Cr | Satisfied |
To see the full charge records of Inventive Impex Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Inventive Impex Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inventive Impex Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Inventive Impex has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCI3028F2ZX | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Inventive Impex Private Limited, buy the company report.
Recent activity
Inventive Impex Private Limited has 14 board changes on record since 2010: 3 appointments and 11 cessations. The latest: Dhruv Aggarwal ceased to be Additional Director on 27 Sep 2024.
12 earlier events are in the company report.
Frequently asked questions
Inventive Impex is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 September 2009 (17+ years old) and is registered under CIN U51909DL2009PTC193882.
Inventive Impex has 3 current directors:
- Shubham Bansal - Director
- Anju Aggarwal - Director
- Dhruv Aggarwal - Director
The latest financial statements of Inventive Impex on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Inventive Impex is 07AACCI3028F2ZX, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Inventive Impex is U51909DL2009PTC193882. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inventive Impex was incorporated on 03 September 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Inventive Impex by revenue are Dolamind Pharmaceutical Private Limited, Amitav Health Care Centre Private Limited, Meddroid Pharmaceutical Private Limited, Styrax Healthcare Private Limited, Coxswain Bio Remedies Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Dhruv Aggarwal ceased to be Additional Director on 27 Sep 2024. Dhruv Aggarwal was appointed as Director on 10 Jun 2024. Anju Aggarwal ceased to be Additional Director on 30 Sep 2021. Inventive Impex has 14 board changes on record in total.
The registered office of Inventive Impex is at I – 4130 Ground Floor Sector – 16 Rohini, New Delhi, Delhi, India – 110089.
Inventive Impex operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Inventive Impex has open charges of ₹11.2 Cr and satisfied charges of ₹4.8 Cr as per latest MCA filings.